Reduction in Cannabis Use and Functional Status in Physical Health, Mental Health, and Cognition
- 3 October 2018
- journal article
- research article
- Published by Springer Nature in Journal of Neuroimmune Pharmacology
- Vol. 13 (4) , 479-487
Abstract
Treatment for substance use disorders has traditionally been abstinence-oriented, but evaluating the merits of low-level cannabis use as potential treatment endpoint may identify benefits that are clinically relevant for treatment-seeking individuals who do not attain abstinence. This study explores if reduction in cannabis use to a lower level of use is related to improved physical health, mental health, and perceived cognitive functions. Study participants with a history of problematic cannabis use (n = 111) completed assessments. Regression models were used to explore the relationship between past 30-day cannabis use levels (abstinent [57%], low use [22%] defined as less than or equal to 3 days per week, and heavy use [22%] defined as 4 or more days of use per week) and functional status in physical health, mental health, and cognition. Compared to heavy users, both abstinent and low-use individuals were similarly associated with better global health, appetite, and depression outcomes. Abstinent users also reported improved sleep, anxiety, and self-reported cognitive functioning relative to heavy users. Thus, reduction in cannabis use to lower levels is associated with beneficial outcomes important to health and other areas of functioning in individuals with problematic cannabis use.Keywords
Funding Information
- National Institute on Drug Abuse (R21DA042280)
This publication has 24 references indexed in Scilit:
- Abstinence and reduced frequency of use are associated with improvements in quality of life among treatment‐seekers with cannabis use disorderThe American Journal on Addictions, 2018
- Trends in registered medical marijuana participation across 13 US states and District of ColumbiaDrug and Alcohol Dependence, 2016
- Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013JAMA Psychiatry, 2015
- An Evidence-Based Review of Acute and Long-Term Effects of Cannabis Use on Executive Cognitive FunctionsJournal of Addiction Medicine, 2011
- Percentage of Subjects With No Heavy Drinking Days: Evaluation as an Efficacy Endpoint for AlcoholClinical TrialsAlcohol, Clinical and Experimental Research, 2010
- How important are sex differences in cannabinoid action?British Journal of Pharmacology, 2010
- Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global itemsQuality of Life Research, 2009
- The Patient-Reported Outcomes Measurement Information System (PROMIS)Medical Care, 2007
- The time course and significance of cannabis withdrawal.Journal of Abnormal Psychology, 2003
- The validity of the Hospital Anxiety and Depression ScaleJournal of Psychosomatic Research, 2002